https://www.reuters.com/business/health ... 023-03-09/
Talk about perfect timing. -Kmall
Bayer's deep pockets working in Dr. Rizo's favor.......
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Re: Bayer's deep pockets working in Dr. Rizo's favor.......
More Deep Pockets with a Possible Interest in Imetelstat
Novo Nordisk to Expand R&D Presence in Boston Area
March 02, 2023
Published March 02, 2023 02:32 AM Eastern Time
Dow Jones Newswires
Danish pharmaceutical company Novo Nordisk AS said Thursday it plans to expand its research and development presence in the greater Boston metropolitan area, creating one of its largest research and development hubs outside of Denmark.
The new hub, which will leverage the company's existing presence in Lexington, Cambridge and Watertown, Massachusetts, will be home to the majority of Novo Nordisk's U.S.-based research and development activities, it said.
The company said it expects to add over 200 new jobs in the Boston area in 2023.
With the establishment of greater Boston as Novo Nordisk's principal research and development location in the U.S., the company will transfer its lab-based discovery activities from Seattle to other locations and will also close the research and development facility in Indianapolis. This is expected to result in the elimination of around 20 positions in Indianapolis and 80 positions in Seattle.
Novo Nordisk said affected employees will be offered the opportunity to pursue open positions at other locations.
The company will continue to have a presence in Seattle, with a focus on digital therapy, data science and artificial intelligence.
Write to Dominic Chopping at dominic.chopping@wsj.com
Novo Nordisk to Expand R&D Presence in Boston Area
March 02, 2023
Published March 02, 2023 02:32 AM Eastern Time
Dow Jones Newswires
Danish pharmaceutical company Novo Nordisk AS said Thursday it plans to expand its research and development presence in the greater Boston metropolitan area, creating one of its largest research and development hubs outside of Denmark.
The new hub, which will leverage the company's existing presence in Lexington, Cambridge and Watertown, Massachusetts, will be home to the majority of Novo Nordisk's U.S.-based research and development activities, it said.
The company said it expects to add over 200 new jobs in the Boston area in 2023.
With the establishment of greater Boston as Novo Nordisk's principal research and development location in the U.S., the company will transfer its lab-based discovery activities from Seattle to other locations and will also close the research and development facility in Indianapolis. This is expected to result in the elimination of around 20 positions in Indianapolis and 80 positions in Seattle.
Novo Nordisk said affected employees will be offered the opportunity to pursue open positions at other locations.
The company will continue to have a presence in Seattle, with a focus on digital therapy, data science and artificial intelligence.
Write to Dominic Chopping at dominic.chopping@wsj.com
Re: Bayer's deep pockets working in Dr. Rizo's favor.......
Novo is crushing it with Ozempic.
Re: Bayer's deep pockets working in Dr. Rizo's favor.......
Ryan - to the tune of $5.6B/yr.
Won't be long until Imetelstat is putting up those numbers. -Kmall
Won't be long until Imetelstat is putting up those numbers. -Kmall
Re: Bayer's deep pockets working in Dr. Rizo's favor.......
Dr. Rizo and Vividion Therapeutics get a mention and interview for Bayer Media Day 2023.....
https://www.healthcareradius.in/rd/new- ... day-berlin
https://www.healthcareradius.in/rd/new- ... day-berlin